Skip to main content
OIDA Image Collection
Filters:
Reset 
A slide from a presentation titled "Case 2: Jennifer: Evaluation". It has a blue background and white text. On the left side of the slide there is a photo of a woman with long brown hair and a serious expression on her face. She is wearing a gray blazer and is standing in front of a white background.<br /><br />The slide is divided into three sections. The first section is titled "Medication History" and has a list of medication history and risk assessment options. The second section has a description of the medication history which includes:<br /><br />- Vicodin (hydrocodone/acetaminophen) 5 mg/mg/mg tablets per day for pain relief<br />- ATC: OxyContin (oxycodone controlled-release) 160 mg/mL<br />- 80 mg tablet for 3 months<br />- Relevant Concomitant Medications<br />- Paroxetine for comorbid anxiety<br /><br />There is also a clinical decision section titled "Trial of EXALGO once daily" which provides information about the treatment options available for the treatment. The third section has an explanation of the risk assessment and a brief description of how the treatment can be used to assess the severity of the condition.

Description Generated using AI

A slide from a presentation titled "Case 2: Jennifer: Evaluation". It has a blue background and white text. On the left side of the slide there is a photo of a woman with long brown hair and a serious expression on her face. She is wearing a gray blazer and is standing in front of a white background.

The slide is divided into three sections. The first section is titled "Medication History" and has a list of medication history and risk assessment options. The second section has a description of the medication history which includes:

- Vicodin (hydrocodone/acetaminophen) 5 mg/mg/mg tablets per day for pain relief
- ATC: OxyContin (oxycodone controlled-release) 160 mg/mL
- 80 mg tablet for 3 months
- Relevant Concomitant Medications
- Paroxetine for comorbid anxiety

There is also a clinical decision section titled "Trial of EXALGO once daily" which provides information about the treatment options available for the treatment. The third section has an explanation of the risk assessment and a brief description of how the treatment can be used to assess the severity of the condition.

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"A slide from a presentation titled "Case 2: Jennifer: Evaluation". It has a blue background and white text. On the left side of the slide t...